Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Anti-infectives Market

Veterinary Anti-infectives Market Trends

  • Report ID: GMI12126
  • Published Date: Nov 2024
  • Report Format: PDF

Veterinary Anti-infectives Market Trends

The rising demand for meat and animal products has significantly increased the need for veterinary anti-infectives in the market. As livestock farming intensifies to meet consumer needs, animals become more susceptible to infections, necessitating effective treatments to maintain their health. Veterinary anti-infectives are crucial for preventing and managing diseases in livestock, ensuring food safety, and reducing the risk of zoonotic diseases that can impact public health. This trend drives market growth.
 

  • For instance, the U.S., a leading beef producer, is currently facing a significant challenge with an outbreak of bird flu among cattle. According to May 2024 reports from the U.S. FDA, over 250 beef products from more than 38 states have tested positive for high-pathogenic avian influenza (HPAI). This situation poses a critical obstacle to beef production but also presents an opportunity for industry players to develop effective therapies to address the outbreak.
     
  • Similarly, South Africa heavily relies on poultry production and has been severely impacted by HPAI, resulting in a substantial 30% decline in egg production and the culling of over a million poultry, as reported by Poultry World in December 2023. These occurrences highlight the urgent need for effective therapies to prevent disease outbreaks in both companion and farmed animals, fostering potential market growth opportunities.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The veterinary anti-infectives industry was valued at USD 5.4 billion in 2023 and is estimated to grow at a 3.5% CAGR from 2024 to 2032, driven by the increasing incidence of infectious diseases in livestock and companion animals.

The livestock animals segment accounted for the largest revenue in 2023 and is expected to maintain its dominance with a 3.4% CAGR through the forecast period, due to the growing need for disease prevention and management in large-scale animal farming.

U.S. veterinary anti-infectives industry was valued at USD 2 billion in 2023 and is anticipated to show considerable growth over the analysis period, driven by advanced healthcare infrastructure, substantial R&D investments, and a high prevalence of infectious diseases.

Key players in the market include Aspen Veterinary Resources, Boehringer Ingelheim International, Ceva, Dechra Pharmaceuticals, Elanco, Merck & Co, Norbrook, Phibro Animal Health, Vetoquinol S.A., Virbac, and Zoetis.

Veterinary Anti-infectives Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 164
  • Countries covered: 19
  • Pages: 150
 Download Free Sample